Separate the signal from the .
Intraday setups detected for you alongside the top movers, from 4am pre-market to 8pm after-hours.
An ocean of opportunity, with the tool to help you realize it.
The Desk is a customizable dashboard where all our features synergize to help you cut the noise. No more chasing — only the best setups find you.
| # | Ticker | Price | Chg | Volume | Mkt Cap | SI % | CTB % | Float | Fuel |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GMM | 4.57 | +147.0% | 138.6M | $8.9M | 10.3% | 482.0% | 45.8M | 52 |
| 2 | JZXN | 2.17 | +85.5% | 146.3M | $2.9M | 5.2% | 513.9% | 1.4M | 45 |
| 3 | NVVE | 13.67 | +55.7% | 18.2M | $7.2M | 3956.1% | 47.6% | 1.3M | 75 |
| 4 | AARD | 7.60 | +52.0% | 4.1M | $165.8M | 4.8% | 0.8% | 12.2M | 4 |
| 5 | SUNE | 3.83 | +49.6% | 76.0M | $15.8M | 8.2% | 481.7% | 3.4M | 49 |
| 6 | ZBAO | 0.4238 | +43.2% | 325.2M | $14.4M | 2.3% | 298.0% | 9.2M | 48 |
| 7 | YMAT | 2.44 | +28.4% | 4.7M | $9.8M | 26.5% | 516.2% | 9.3M | 62 |
| 8 | SNAL | 4.94 | +26.7% | 5.7M | $43.7M | 11.7% | 31.8% | 13.5M | 30 |
Acquiring Vega Therapeutics' VWD drug for up to $2B
FT819 lupus Phase 2 registrational trial with FDA RMAT support
MIRACLE trial: favorable early efficacy for Annamycin in r/r AML
First AI/robotics M&A deal; definitive close expected mid-July
Buyer- vs seller-initiated dollars (tick-rule classified). Net flow on the right.
Never be the last to know
Most traders find the setup after the move. Six instruments, built to put you on the early side of it.
Open the chart. The homework is done.
Every night, 11,000+ charts get their trend lines drawn, their pattern named, and a reliability score. You wake up to the shortlist.
Catch it at 4am, not 4pm
Movers stream from pre-market to after-hours, patterns detected while they run. By the time it's on a feed, you've been watching.
Acquiring Vega Therapeutics' VWD drug for up to $2B
FT819 lupus Phase 2 registrational trial · FDA RMAT support
Know the why, before the crowd
An AI analyst reads every US stock's filings and newswires — what's coming, how big, when. Cash runway and dilution risk included.
See who's really buying
Every tick, rebuilt into real orders — who lifted the offer, who hit the bid, what smart-size money did while the chart looked red.
One question. The whole market answers.
Stack price, float, short interest, pattern and flow into a single screen — running on live prices, not last night's.
Lists that tap your shoulder
Performance vs the S&P, order flow per ticker, intraday alerts, a morning digest. Your list does the watching.
Other scanners can tell you what's moving. Ours will tell you why.
Here's the part every scanner does — and the part we built because nobody did.
BreakoutScanOthersIndustry-leading scannersNo feature tiers, no add-ons. Everything above is in the one plan below.
One plan. Everything.
Less than one mistimed entry costs — and you don't pay a cent until you've traded with it for a week.
- Nightly pattern scanner — trend lines drawn across 11,000+ stocks
- Real-time runners — pre-market, regular & after-hours
- Catalyst board with impact scoring, cash runway & dilution risk
- Unusual-orders tape + watchlist order-flow analytics
- Full Scan screener with live prices
- Multi-window Desk, unlimited watchlists, alerts & daily digest
$0 today · cancel in one click · founding rate locked while you stay
*Your founding rate never goes up for as long as your subscription stays active. Regular price $99/mo applies once the first 100 spots are gone.
- Nightly pattern scanner — trend lines drawn across 11,000+ stocks
- Real-time runners — pre-market, regular & after-hours
- Catalyst board with impact scoring, cash runway & dilution risk
- Unusual-orders tape + watchlist order-flow analytics
- Full Scan screener with live prices
- Multi-window Desk, unlimited watchlists, alerts & daily digest
$0 today · yearly billing starts after your trial
Questions
Do I need a credit card to start?
Yes — your 7-day free trial requires a card so you can keep going seamlessly if you love it. You won't be charged until day 7, and you can cancel anytime in one click before then.
What happens after the trial?
If you don't cancel, your card is charged $79/month (the founding-member rate — regular price is $99) for full access. Cancel before day 7 and you're charged nothing.
What does 'founding member' mean?
The first 100 accounts get BreakoutScan Pro at $79/month instead of the regular $99 — and that rate is locked in for as long as your subscription stays active. No games: if you cancel and come back later, you rejoin at whatever the price is then.
What markets and data do you cover?
The full US equities market — listed names stream in real time; pattern detection runs on daily and intraday timeframes. Catalyst coverage focuses on small-caps where events move price most.
Do I need to be an expert?
No — that's the point. BreakoutScan explains what it finds in plain English: what the pattern is, why the catalyst matters, and when it's expected. It's built to be your market best friend, not another intimidating terminal.
Is this financial advice?
No. BreakoutScan is a research and education tool. Patterns, scores, and catalysts are informational — always do your own diligence.
The next breakout is already forming.
Be looking at it when it happens — your first week is on us.
Start your 7-day free trial$0 today · one-click cancel